Credit Suisse’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-879
| Closed | -$29K | – | 3470 |
|
|
2019
Q1 | $29K | Buy |
+879
| New | +$29K | ﹤0.01% | 3332 |
|
|
2018
Q4 | – | Sell |
-1,659
| Closed | -$233K | – | 3371 |
|
|
2018
Q3 | $233K | Sell |
1,659
-934
| -36% | -$131K | ﹤0.01% | 3139 |
|
|
2018
Q2 | $319K | Buy |
+2,593
| New | +$319K | ﹤0.01% | 3150 |
|
|
2017
Q3 | – | Sell |
-5,585
| Closed | -$235K | – | 3711 |
|
|
2017
Q2 | $235K | Buy |
+5,585
| New | +$235K | ﹤0.01% | 3185 |
|
|
2017
Q1 | – | Sell |
-3,205
| Closed | -$122K | – | 3526 |
|
|
2016
Q4 | $122K | Buy |
3,205
+2,130
| +198% | +$81.1K | ﹤0.01% | 3553 |
|
|
2016
Q3 | $42K | Sell |
1,075
-2,195
| -67% | -$85.8K | ﹤0.01% | 3687 |
|
|
2016
Q2 | $234K | Buy |
3,270
+1,043
| +47% | +$74.6K | ﹤0.01% | 3495 |
|
|
2016
Q1 | $178K | Sell |
2,227
-2,365
| -52% | -$189K | ﹤0.01% | 3418 |
|
|
2015
Q4 | $346K | Buy |
4,592
+3,853
| +521% | +$290K | ﹤0.01% | 3391 |
|
|
2015
Q3 | $284K | Sell |
739
-3,366
| -82% | -$1.29M | ﹤0.01% | 3540 |
|
|
2015
Q2 | $1.71M | Buy |
4,105
+1,993
| +94% | +$828K | ﹤0.01% | 2447 |
|
|
2015
Q1 | $1M | Buy |
2,112
+1,368
| +184% | +$650K | ﹤0.01% | 2723 |
|
|
2014
Q4 | $275K | Buy |
+744
| New | +$275K | ﹤0.01% | 3733 |
|